AI assistant
Sending…
Bone Biologics Corp — Director's Dealing 2021
Oct 21, 2021
35440_dirs_2021-10-21_4d383a45-3741-414b-9565-7784f6ede2eb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Bone Biologics Corp (BBLG)
CIK: 0001419554
Period of Report: 2021-10-15
Reporting Person: Angle Siddhesh Rajendra (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Options to Purchase Common Stock | $5.25 | 2031-10-15 | Common Stock (50000) | Direct |
More from Bone Biologics Corp
Interim / Quarterly Report
2026
May 14
Annual Report
2026
Mar 2
Director's Dealing
2026
Jan 21
Director's Dealing
2026
Jan 21
Regulatory Filings
2026
Jan 8
Interim / Quarterly Report
2025
Nov 14
Major Shareholding Notification
2025
Nov 7
Capital/Financing Update
2025
Sep 26
Regulatory Filings
2025
Sep 4
Regulatory Filings
2025
Aug 29